Tuesday, 27 September 2016
Topical Issue Debate
Medicinal Products Availability
I received a telephone call last Saturday from a gentleman in Cork in regard to his wife who suffers from lupus and has been in chronic pain for the past 20 years. The man's wife has been told by her neurologist that if she could access Sativex, which is an oral spray used typically by people who suffer from multiple sclerosis, it could help her condition. I understand that in July 2014 the use of Sativex was licensed in Ireland but that agreement on price has yet to be reached between the HSE and the manufacturers. There are many people who could benefit from treatment with this drug. When will a price on Sativex be agreed between the HSE and the manufacturer so this drug is accessible to people, particularly the wife of the man who contacted me and people suffering from multiple sclerosis?